The compounding pharmacy pulled the injections voluntarily, saying it could not assure they were sterile. Check the recall notice if you use compounded tirzepatide.
Recap by typeshit. Full story at Los Angeles Times on MSN.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
BigGo Finance reports women in the CagriSema trial lost more weight than the study population as a whole.
Loading…